Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 29.10.2020
Befesa S.A.
DGAP-Media / 29.10.2020 / 07:30
/
PRESS AND INVESTOR ANNOUNCEMENT
Third quarter 2020 results
Befesa sees beginning of moderate recovery in Q3 2020
- Q3 2020 EBITDA at €29m, slightly above market expectations; 9M 2020 EBITDA at €85m
- Continued quarter-on-quarter (QoQ) recovery following COVID-19 induced low of €22m EBITDA in Q2; zinc a [ … ]
Thu, 29.10.2020
GRENKE AG
GRENKE AG reinforces Board of Directors and integrates franchise system
Franchise companies to be integrated into the Consolidated Group in the upcoming 12 to 18 months
Board of Directors to be expanded to include a Chief Risk Officer (CRO) responsible for the areas of risk control, legal and compliance
Reallocation of Board of Directors' respon [ … ]
Thu, 29.10.2020
GRENKE AG
Q3 2020: GRENKE increases net interest income year-on-year despite the corona pandemic
Net interest income increases 2.5% to EUR 96.0 million (Q3 2019: EUR 93.6 million)
Settlement of claims and risk provision amounts to EUR 48.8 million (Q3 2019: EUR 32.2 million) as a result of the corona pandemic and IFRS 9 provisions
Net profit equals EUR 17 [ … ]
Thu, 29.10.2020
DEMIRE Deutsche Mittelstand Real Estate AG
DEMIRE realises potential by selling a real estate portfolio
- 13 properties sold as part of strategic portfolio streamlining
- Sales proceeds of around EUR 85.2 million are above market value and will be used for acquisitions and further portfolio optimisation
- Guidance for the 2020 financial year confirmed despite the transactions
Langen, 2 [ … ]
Thu, 29.10.2020
Fresenius Medical Care AG & Co. KGaA
- Operations maintained despite COVID-19, impact on patients minimized
- Q3 development impacted by currency headwinds and expected lower reimbursement for calcimimetics
- Financial targets for FY 2020 confirmed inclusive of anticipated COVID-19 effects
"The global COVID-19 pandemic has posed further challenges to us in the third quarter; and it [ … ]
Thu, 29.10.2020
Aroundtown SA
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS
AROUNDTOWN CONTINUES STRONG DISPOSAL ACTIVITY AND ANNOUNCES FINAL COMPOSITION OF MANA [ … ]
Thu, 29.10.2020
Takeda Pharmaceutical Company Limited
Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
Osaka, Japan, October 29, 2020 - Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") announced today, the revised forecast of the full year consolidated financials for the fiscal year ending March 31, 2021, as below.
1. Revised Forecast for Full Year Cons [ … ]
Thu, 29.10.2020
Nemetschek SE
Corporate News
Nemetschek Group shows favorable business development in the third quarter and raises outlook for the full year 2020
- Group revenue rises by +7.5% (currency-adjusted: +10.3%) to EUR 148.6 million in Q3
- Quarterly growth driven by recurring revenue (+18.0%), especially as a result of growing demand for subscription models
- Cos [ … ]
Thu, 29.10.2020
TAKKT AG
TAKKT sees stabilization of business in the third quarter
Organic sales development improved to minus 12.2 percent
Cost management continued while flexibly adjusting expenses to the stabilizing demand
EBITDA in the third quarter at 22.5 million euros; in addition to the decrease in sales, one-time costs had a negative impact on earnings
Free TA [ … ]
Thu, 29.10.2020
Wacker Chemie AG
WACKER'S Q3 2020 SALES REACH €1.18 BILLION, UP 10 PERCENT QUARTER OVER QUARTER, BUT DOWN 7 PERCENT YEAR OVER YEAR DUE TO IMPACT OF CORONAVIRUS PANDEMIC
AT €191 MILLION, EBITDA IS 81 PERCENT HIGHER VERSUS A QUARTER AGO, BUT 30 PERCENT LOWER THAN LAST YEAR DUE TO SPECIAL INCOME POSTED IN Q3 2019
NET INCOME FOR Q3 2020 AMOUNTS TO €68 MILLION
PROVIS [ … ]